Intercontinental Exchange, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Intercontinental Exchange, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2017 | $5.84B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $5.97B | Feb 7, 2019 |
| FY2017 | Dec 31, 2015 | $4.68B | Feb 7, 2018 |
| FY2016 | Dec 31, 2014 | $4.35B | Feb 7, 2017 |
| FY2015 | Dec 31, 2013 | $1.73B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $1.36B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $1.33B | Feb 14, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.64B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $11.76B | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $9.90B | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $9.64B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $9.17B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $8.24B | Feb 2, 2023 |
| FY2021 | Dec 31, 2019 | $6.55B | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $6.28B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $5.84B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $5.97B | Feb 7, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.32B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $2.75B | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $2.37B | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $1.45B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $4.06B | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | $526.00M | Feb 4, 2021 |
| FY2020 | Sep 30, 2020 | $390.00M | Feb 4, 2021 |
| FY2020 | Jun 30, 2020 | $523.00M | Feb 4, 2021 |
| FY2020 | Mar 31, 2020 | $650.00M | Feb 4, 2021 |
| FY2020 | Dec 31, 2019 | $448.00M | Feb 4, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.93B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $4.31B | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $3.69B | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $3.64B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $3.45B | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | $780.00M | Feb 4, 2021 |
| FY2020 | Sep 30, 2020 | $627.00M | Feb 4, 2021 |
| FY2020 | Jun 30, 2020 | $744.00M | Feb 4, 2021 |
| FY2020 | Mar 31, 2020 | $882.00M | Feb 4, 2021 |
| FY2020 | Dec 31, 2019 | $622.00M | Feb 4, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $293.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $307.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $266.00M | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $226.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $215.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $185.00M | Feb 2, 2023 |
| FY2021 | Dec 31, 2019 | $161.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $151.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $155.00M | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $116.00M | Feb 7, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.66B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $4.61B | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $3.54B | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $3.55B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $3.12B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $2.88B | Feb 2, 2023 |
| FY2021 | Dec 31, 2019 | $2.66B | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $2.53B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $2.09B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $2.15B | Feb 7, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $373.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $406.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $190.00M | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $225.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $179.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $207.00M | Feb 2, 2023 |
| FY2021 | Dec 31, 2019 | $153.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $134.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $220.00M | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $250.00M | Feb 7, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.89B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $139.43B | Feb 5, 2026 |
| FY2024 | Dec 31, 2023 | $136.08B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $194.34B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $193.50B | Feb 2, 2023 |
| FY2021 | Dec 31, 2020 | $126.20B | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | $94.49B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $92.79B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $78.26B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $82.00B | Feb 7, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $107.90B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $111.71B | Feb 5, 2026 |
| FY2024 | Dec 31, 2023 | $110.30B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $171.58B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $170.75B | Feb 2, 2023 |
| FY2021 | Dec 31, 2020 | $106.57B | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | $77.13B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $75.49B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $61.28B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $66.21B | Feb 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.92B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $27.65B | Feb 5, 2026 |
| FY2024 | Dec 31, 2023 | $25.72B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $22.71B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $22.71B | Feb 2, 2023 |
| FY2021 | Dec 31, 2020 | $19.50B | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | $17.26B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $17.20B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $16.96B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $15.72B | Feb 7, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.65B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $30.60B | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $30.55B | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $21.11B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $21.12B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $21.29B | Feb 2, 2023 |
| FY2021 | Dec 31, 2019 | $13.34B | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $13.09B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $12.22B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $12.29B | Feb 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.28B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $18.07B | Feb 5, 2026 |
| FY2024 | Dec 31, 2023 | $16.36B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $14.94B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $14.35B | Feb 2, 2023 |
| FY2021 | Dec 31, 2020 | $11.04B | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | $9.63B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $8.32B | Feb 6, 2020 |
| FY2019 | Dec 31, 2017 | $6.86B | Feb 6, 2020 |
| FY2017 | Dec 31, 2016 | $4.79B | Feb 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $837.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $844.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $899.00M | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $1.80B | Feb 6, 2025 |
| FY2017 | Dec 31, 2017 | $1.57B | Feb 7, 2018 |
| FY2017 | Dec 31, 2016 | $1.35B | Feb 7, 2018 |
| FY2017 | Dec 31, 2015 | $1.55B | Feb 7, 2018 |
| FY2017 | Dec 31, 2014 | $1.28B | Feb 7, 2018 |
| FY2015 | Dec 31, 2013 | $961.00M | Feb 4, 2016 |
| FY2016 | Dec 31, 2012 | $961.00M | Feb 7, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $18.12B | Feb 2, 2023 |
| FY2021 | Dec 31, 2021 | $13.92B | Feb 3, 2022 |
| FY2020 | Dec 31, 2020 | $16.54B | Feb 4, 2021 |
| FY2019 | Dec 31, 2019 | $7.82B | Feb 6, 2020 |
| FY2018 | Dec 31, 2018 | $7.44B | Feb 7, 2019 |
| FY2017 | Dec 31, 2017 | $6.10B | Feb 7, 2018 |
| FY2016 | Dec 31, 2016 | $6.36B | Feb 7, 2017 |
| FY2015 | Dec 31, 2015 | $7.31B | Feb 4, 2016 |
| FY2014 | Dec 31, 2014 | $2.25B | Feb 5, 2015 |
| FY2014 | Dec 31, 2013 | $3.92B | Feb 5, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 4, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 4, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 4, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 4, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 4, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 4, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 4, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 4, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 4, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 4, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 567.00M | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | 574.00M | Feb 5, 2026 |
| FY2024 | Dec 31, 2023 | 573.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | 559.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | 561.00M | Feb 2, 2023 |
| FY2021 | Dec 31, 2020 | 561.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | 554.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | 569.00M | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | 583.00M | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | 595.00M | Feb 7, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 5, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 5, 2026 |
| FY2025 | Dec 31, 2023 | $955.00M | Feb 5, 2026 |
| FY2024 | Dec 31, 2022 | $853.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $747.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $669.00M | Feb 2, 2023 |
| FY2021 | Dec 31, 2019 | $621.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $555.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $476.00M | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $409.00M | Feb 7, 2019 |